Thomas de Shazo

Thomas De Shazo possesses extensive experience in the fields of neurotherapeutics, clinical research, and investment management. Currently serving as a Board Member and Director at Molecular Defenses Corporation and AVIRA Capital since January 2021, Thomas is involved in neurotherapeutic clinical studies and applied translational CNS research, with a focus on treatments for traumatic brain injury and neurodegenerative diseases. As a Partner at ADVOCATUS LLP, Thomas contributes to legal representation for sovereign nations and commercial entities. Thomas has also held various leadership roles, including Director of Molecular Defenses Corporation and Founder of MineInvest Resources LLC, where engagements in advanced therapeutic technologies and mining project financing are paramount. Academic credentials include studies at Harvard and Boise State University.